首页|期刊导航|癌症生物学与医学（英文版）|Harnessing the microbiome:a new frontier in lung cancer immunotherapy

Harnessing the microbiome:a new frontier in lung cancer immunotherapy

Kexin Feng Jun Wang Shuai Wang Zewen Sun Mantang Qiu Zuli Zhou Yun Li Kezhong Chen

癌症生物学与医学（英文版）2026，Vol.23Issue(8)：1057-1086,30.

癌症生物学与医学（英文版）2026，Vol.23Issue(8)：1057-1086,30.DOI:10.20892/j.issn.2095-3941.2025.0177

Harnessing the microbiome:a new frontier in lung cancer immunotherapy

Kexin Feng ¹Jun Wang ¹Shuai Wang ¹Zewen Sun ¹Mantang Qiu ¹Zuli Zhou ¹Yun Li ¹Kezhong Chen¹

作者信息

1. Department of Thoracic Surgery,Peking University People's Hospital,Beijing 100044,China||Thoracic Oncology Institute,Peking University People's Hospital,Beijing 100044,China||Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer,Chinese Academy of Medical Sciences,Peking University People's Hospital,Beijing 100044,China
折叠

摘要

关键词

Lung cancer/immunotherapy/microbiome/biomarkers/gut-lung axis/microbial metabolites

Key words

Lung cancer/immunotherapy/microbiome/biomarkers/gut-lung axis/microbial metabolites

引用本文复制引用

Kexin Feng,Jun Wang,Shuai Wang,Zewen Sun,Mantang Qiu,Zuli Zhou,Yun Li,Kezhong Chen..Harnessing the microbiome:a new frontier in lung cancer immunotherapy[J].癌症生物学与医学（英文版）,2026,23(8):1057-1086,30.

基金项目

This work was supported by the Beijing Natural Science Foundation(Grant Nos.Z240013,L234002,and L222021),the Beijing Research Ward Excellence Program(Grant Nos.BRWEP2024W034080200 and BRWEP2024W034080204),the Chinese Academy of Medical Sciences(Grant No.2021RU002),the National Natural Science Foundation of China(Grant Nos.92259303,82388102,82450111,82373416,and 82573950),the CAMS Medical and Health Science and Technology Innovation Project(Grant No.2021-I2M-5-002),and the Peking University People's Hospital Research and Development Funds(Grant No.RZG2024-02). （Grant Nos.Z240013,L234002,and L222021）

癌症生物学与医学（英文版）

ISSN：2095-3941

访问量0

下载量0

段落导航